Abstract
Injectable gel implants using poly(lactic-co-glycolic) acid (PLGA) for methotrexate were prepared. In-vitro release was observed for 10-12 days and was dependent on PLGA concentration. The antitumour efficacy in mice bearing sarcoma-180 was improved as revealed by the volume doubling time. The drug plasma levels were sustained for more than 2 weeks.
| Original language | English |
|---|---|
| Pages (from-to) | 133-136 |
| Number of pages | 4 |
| Journal | Pharmaceutical Sciences |
| Volume | 3 |
| Issue number | 3 |
| Publication status | Published - 1997 |
All Science Journal Classification (ASJC) codes
- Pharmaceutical Science
Fingerprint
Dive into the research topics of 'Enhanced antitumour efficacy of methotrexate poly(lactic-co-glycolic) acid injectable gel implants in mice bearing sarcoma-180'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver